Yüklüyor......
Latanoprostene bunod ophthalmic solution 0.024%: a new treatment option for open‐angle glaucoma and ocular hypertension
Latanoprostene bunod (LBN) ophthalmic solution 0.024% is a novel, once‐daily, nitric oxide‐donating prostaglandin analogue for the lowering of intraocular pressure (IOP) in patients with open‐angle glaucoma and ocular hypertension. The IOP‐lowering actions of LBN are mediated by dual mechanisms of t...
Kaydedildi:
| Yayımlandı: | Clin Exp Optom |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wiley Publishing Asia Pty Ltd
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6899723/ https://ncbi.nlm.nih.gov/pubmed/30614563 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cxo.12853 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|